Engineered CD25 polypeptides and uses thereof
Provided herein engineered polypeptides that comprise a combination of spatially-associated topological constraints, wherein at least one constraint is derived from a CD25 reference target, and methods of selecting the engineered polypeptides. Further provided are methods of using the engineered pol...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided herein engineered polypeptides that comprise a combination of spatially-associated topological constraints, wherein at least one constraint is derived from a CD25 reference target, and methods of selecting the engineered polypeptides. Further provided are methods of using the engineered polypeptides, including as positive and/or negative selection molecules in methods of screening a library of binding molecules such as antibodies. Further provided herein are CD25 antibodies selected using these engineered polypeptides.
本文提供了包含空间相关拓扑约束的组合的工程化多肽,其中至少一个约束源自CD25参考靶标;以及选择所述工程化多肽的方法。还提供了使用所述工程化多肽的方法,包括在筛选结合分子如抗体的文库的方法中作为阳性和/或阴性选择分子。本文还提供了使用这些工程化多肽选择的CD25抗体。 |
---|